Universal Health Services Inc.

UHS | NYSE

Price Alert Chart Builder DCF Calculator

$174.74

-$1.95 (-1.10%)

At close: Sep 21, 2026, 4:00 PM ET

$173.72

-$1.02 (-0.58%)

Pre-market: Sep 22, 2026, 6:15 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $10.58B

Enterprise Value $15.7B

Beta 1.06

Average Volume 965.54K

Shares Outstanding (Diluted) 61.71M

Shares Change YoY -5.04%

Institutional Ownership 84.47%

Exchange NYSE

ISIN US9139031002

Price Performance

Price Change 1M -1.9%

Price Change 3M 19.8%

Price Change 6M -6.4%

Price Change YTD -20.5%

Price Change 1Y -10.0%

Price Change 3Y 37.6%

Price Change 5Y 20.7%

1M CAGR (ann.) 0.8%

1Y CAGR (ann.) -6.7%

5Y CAGR (ann.) 3.7%

All-Time CAGR 10.6%

Valuation

PE Ratio 7.22

Forward PE 6.85

PEG Ratio 0.26

Forward PEG 1.12

PS Ratio 0.58

Forward PS 0.50

PB Ratio 1.41

P/FCF Ratio 12.80

P/Adj. FCF Ratio 13.59

P/OCF Ratio 5.79

EV/Sales 0.87

EV/EBIT 7.20

EV/EBITDA 5.57

EV/FCF 18.99

Earnings Yield 13.8%

FCF Yield 7.8%

Adj. FCF Yield 7.4%

Financial Health

Net Debt $4.78B

Total Debt $5.26B

Cash & Short-Term Investments $138.8M

Total Assets $15.94B

Current Ratio 1.12

Quick Ratio 1.04

Debt / Equity Ratio 0.70

Debt / EBITDA 1.87

Debt / FCF 6.37

OCF / Debt 0.34

Interest Coverage 13.22

Altman Z-Score 2.38

Piotroski F-Score 7

Margins & Profitability

Gross Profit Margin 90.7%

Operating Profit Margin 11.4%

EBITDA Margin 15.6%

Net Profit Margin 8.4%

FCF Margin 4.6%

Adj. FCF Margin 4.3%

SBC / Revenue 0.3%

SBC Impact (per share) -5.9%

Returns

Return on Assets 9.6%

Return on Equity 20.7%

Return on Invested Capital 11.7%

Return on Capital Employed 16.3%

Return on Tangible Assets 12.8%

Historical Growth (CAGR)

Revenue CAGR 3Y 9.5%

Revenue CAGR 5Y 8.2%

Revenue CAGR 10Y 6.8%

EPS CAGR 3Y 36.0%

EPS CAGR 5Y 13.9%

EPS CAGR 10Y 13.2%

FCF CAGR 3Y 17.6%

FCF CAGR 5Y 37.3%

FCF CAGR 10Y 10.4%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 44

EPS Growth Next 3Y 2.2%

Revenue Growth Next 3Y 5.4%

Earnings Date Oct 25, 2026

EPS Estimate (next Q) $5.24

EPS Growth Est (next Q) -7.9%

Revenue Est (next Q) $4.71B

Revenue Growth Est (next Q) 4.9%

Fair Value Estimates

Graham Number $264.42

Graham Upside 51.3%

Lynch Fair Value $336.03

Lynch Upside 92.3%

Price Target $193

Price Target Upside 10.4%

Cash Flow

Operating Cash Flow $1.8B

Free Cash Flow $826.72M

Adj. Free Cash Flow $778.35M

FCF Per Share $13.86

OCF Per Share $30.19

OCF/S Ratio 9.9%

Income Statement

Revenue $18.11B

Gross Profit $9.32B

Operating Income $2.06B

EBITDA $2.82B

Net Income $1.53B

EPS (Diluted) $24.21

Revenue / Employee $178.47K

Profit / Employee $15.03K

Employees 101,500

Dividends

Annual Dividend $0.80

Dividend Yield 0.46%

Payout Ratio 3.3%

FCF Payout Ratio 6.0%

Adj. FCF Payout Ratio 6.4%

Dividend Growth (YoY) 0.0%

Pay Frequency Quarterly

Ex-Dividend Date Aug 31, 2026